161 related articles for article (PubMed ID: 25405889)
1. Antiadhesion agents against Gram-positive pathogens.
Cascioferro S; Cusimano MG; Schillaci D
Future Microbiol; 2014; 9(10):1209-20. PubMed ID: 25405889
[TBL] [Abstract][Full Text] [Related]
2. Sortase A: an ideal target for anti-virulence drug development.
Cascioferro S; Totsika M; Schillaci D
Microb Pathog; 2014 Dec; 77():105-12. PubMed ID: 25457798
[TBL] [Abstract][Full Text] [Related]
3. Antivirulence as a new antibacterial approach for chemotherapy.
Escaich S
Curr Opin Chem Biol; 2008 Aug; 12(4):400-8. PubMed ID: 18639647
[TBL] [Abstract][Full Text] [Related]
4. [Study of antibiotic influence on adherence capacity of gram positive and gram negative bacteria to the cellular substrate].
Balotescu C; Israil AM; Lazăr V; Cernat R; Petrache LM; Dinu C
Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):131-5. PubMed ID: 15085601
[TBL] [Abstract][Full Text] [Related]
5. Forthcoming therapeutic perspectives for infections due to multidrug-resistant Gram-positive pathogens.
Cornaglia G; Rossolini GM
Clin Microbiol Infect; 2009 Mar; 15(3):218-23. PubMed ID: 19335369
[TBL] [Abstract][Full Text] [Related]
6. The use of sortase-mediated ligation for the immobilisation of bacterial adhesins onto fluorescence-labelled microspheres: a novel approach to analyse bacterial adhesion to host cells.
Wu S; Proft T
Biotechnol Lett; 2010 Nov; 32(11):1713-8. PubMed ID: 20623314
[TBL] [Abstract][Full Text] [Related]
7. Bacterial adhesion to respiratory mucosa and its modulation by antibiotics at sub-inhibitory concentrations.
Piatti G
Pharmacol Res; 1994 Dec; 30(4):289-99. PubMed ID: 7716103
[TBL] [Abstract][Full Text] [Related]
8. [Possibility of drug design of beta-lactam antibiotics effective for multiresistant gram-positive pathogens].
Okonogi K; Miyake A
Nihon Rinsho; 1997 May; 55(5):1261-5. PubMed ID: 9155184
[TBL] [Abstract][Full Text] [Related]
9. A review on antimicrobial activity of mushroom (Basidiomycetes) extracts and isolated compounds.
Alves MJ; Ferreira IC; Dias J; Teixeira V; Martins A; Pintado M
Planta Med; 2012 Nov; 78(16):1707-18. PubMed ID: 23023950
[TBL] [Abstract][Full Text] [Related]
10. Identification of pili on the surface of Finegoldia magna--a gram-positive anaerobic cocci.
Murphy EC; Janulczyk R; Karlsson C; Mörgelin M; Frick IM
Anaerobe; 2014 Jun; 27():40-9. PubMed ID: 24685556
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a novel nitroimidazolyl-oxazolidinone hybrid with potent anti Gram-positive activity: Synthesis and antibacterial evaluation.
Khalaj A; Nakhjiri M; Negahbani AS; Samadizadeh M; Firoozpour L; Rajabalian S; Samadi N; Faramarzi MA; Adibpour N; Shafiee A; Foroumadi A
Eur J Med Chem; 2011 Jan; 46(1):65-70. PubMed ID: 21071113
[TBL] [Abstract][Full Text] [Related]
12. Fighting infections due to multidrug-resistant Gram-positive pathogens.
Cornaglia G
Clin Microbiol Infect; 2009 Mar; 15(3):209-11. PubMed ID: 19335367
[TBL] [Abstract][Full Text] [Related]
13. Candidate targets for new antivirulence drugs: selected cases of bacterial adhesion and biofilm formation.
Klemm P; Hancock V; Kvist M; Schembri MA
Future Microbiol; 2007 Dec; 2(6):643-53. PubMed ID: 18041905
[TBL] [Abstract][Full Text] [Related]
14. Gram-positive bacterial resistance. A challenge for the next millennium.
Bassetti M; Melica G; Cenderello G; Rosso R; Di Biagio A; Bassetti D
Panminerva Med; 2002 Sep; 44(3):179-84. PubMed ID: 12094131
[TBL] [Abstract][Full Text] [Related]
15. Antivirulence drugs to target bacterial secretion systems.
Baron C
Curr Opin Microbiol; 2010 Feb; 13(1):100-5. PubMed ID: 20079679
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of action of newer antibiotics for Gram-positive pathogens.
Hancock RE
Lancet Infect Dis; 2005 Apr; 5(4):209-18. PubMed ID: 15792738
[TBL] [Abstract][Full Text] [Related]
17. Bacterial adhesion--a source of alternate antibiotic targets.
Cusumano CK; Hultgren SJ
IDrugs; 2009 Nov; 12(11):699-705. PubMed ID: 19844856
[TBL] [Abstract][Full Text] [Related]
18. Sources of novel antibiotics--aside the common roads.
Donadio S; Maffioli S; Monciardini P; Sosio M; Jabes D
Appl Microbiol Biotechnol; 2010 Dec; 88(6):1261-7. PubMed ID: 20865256
[TBL] [Abstract][Full Text] [Related]
19. Small-molecule AgrA inhibitors F12 and F19 act as antivirulence agents against Gram-positive pathogens.
Greenberg M; Kuo D; Jankowsky E; Long L; Hager C; Bandi K; Ma D; Manoharan D; Shoham Y; Harte W; Ghannoum MA; Shoham M
Sci Rep; 2018 Oct; 8(1):14578. PubMed ID: 30275455
[TBL] [Abstract][Full Text] [Related]
20. A multivalent approach to drug discovery for novel antibiotics.
Long DD; Aggen JB; Christensen BG; Judice JK; Hegde SS; Kaniga K; Krause KM; Linsell MS; Moran EJ; Pace JL
J Antibiot (Tokyo); 2008 Oct; 61(10):595-602. PubMed ID: 19168973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
